sind doch schöne Aussichten.... LAKE OSWEGO, Ore., March 29 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (Nachrichten) today announces its financial results for the fourth quarter and year For the fourth quarter ended December 31, 2005, Calypte recorded revenues of $133,000, compared with $33,000 in the fourth quarter in 2004. The net loss for the quarter was approximately $754,000 or $0.004 compared with a net loss of $6.2 million or $0.04 per common share for the three months ended December 31, 2004.
For the year-ended December 31, 2005, Calypte reported revenues of $427,000, compared with $531,000 in 2004. The 2004 revenue included $500,000 of deferred revenue related to a 1994 distribution agreement with a Japanese distributor. The net loss for 2005 was $8.8 million or $0.05 per common share compared with a net loss of $17.3 million, or $0.11 per common share, for the year ended December 31, 2004. |